SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-220579
Filing Date
2017-07-03
Accepted
2017-07-03 06:08:56
Documents
2
Effectiveness Date
2017-07-03

Document Format Files

Seq Description Document Type Size
1 DFAN14A d414748ddfan14a.htm DFAN14A 18252
2 GRAPHIC g414748g35h18.jpg GRAPHIC 4569
  Complete submission text file 0001193125-17-220579.txt   26253
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Subject) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-36395 | Film No.: 17944053
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3216 CAMINITO EASTBLUFF, 67 LA JOLLA CA 92037
Business Address 3216 CAMINITO EASTBLUFF, 67 LA JOLLA CA 92037 (858) 395-4483
DARE BIOSCIENCE, INC. (Filed by) CIK: 0001701808 (see all company filings)

IRS No.: 474813108 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A